Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
QuintilesIMS
Boehringer Ingelheim
Moodys
Healthtrust
Julphar
Fuji
Teva

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021845

« Back to Dashboard

NDA 021845 describes REVATIO, which is a drug marketed by Pfizer and is included in three NDAs. It is available from five suppliers. Additional details are available on the REVATIO profile page.

The generic ingredient in REVATIO is sildenafil citrate. There are twenty drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the sildenafil citrate profile page.
Summary for 021845
Tradename:REVATIO
Applicant:Pfizer
Ingredient:sildenafil citrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021845
Medical Subject Heading (MeSH) Categories for 021845
Suppliers and Packaging for NDA: 021845
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
REVATIO sildenafil citrate TABLET;ORAL 021845 NDA Pfizer Laboratories Div Pfizer Inc 0069-4190 0069-4190-68 90 TABLET, FILM COATED in 1 BOTTLE (0069-4190-68)
REVATIO sildenafil citrate TABLET;ORAL 021845 NDA AUTHORIZED GENERIC KAISER FOUNDATION HOSPITALS 0179-0160 0179-0160-08 8 TABLET, FILM COATED in 1 BOTTLE (0179-0160-08)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Jun 3, 2005TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Medtronic
Johnson and Johnson
US Army
Argus Health
Deloitte
Chubb
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.